The total European laparoscope market is expected to grow and approach a value of €60 million by 2023 despite experiencing minor pricing declines over the next several years due to a competitive market.
Vancouver, BC -- (ReleaseWire) -- 12/15/2017 -- According to a new series of reports on the European market for laparoscopic devices by iData Research (www.idataresearch.com), decreased hospital budgets will limit the growth of new rod and video laparoscope sales in the region. As a result, lower cost refurbished laparoscopes are gaining popularity, as sterilization techniques are improving to ensure patient health and safety.
"With Karl Storz, Richard Wolf, Stryker, Olympus, ConMed, B. Braun and a few other smaller companies all competing for market share, there is downward pressure on the average selling price for these devices," explains Jeffrey Wong, Strategic Analyst Manager at iData Research. "Companies are not only competing with the quality of their products, but the quality of their refurbishment and replacement plans."
The laparoscope rod lens market is predicted to grow at a slower rate compared to video lenses. The video lens market covers all forms of video lenses such as HD, 4k and 3D video lenses. The expected emergence of 3D systems over the next few years will take market share from the standard video laparoscope market. Hospitals looking to purchase the newest technology will now have more alternatives.
Integrated video systems typically include a laparoscope, and provide a single input and feedback point for multiple devices. They often provide price advantages to the buyer, creating cost savings for each separate component. Integrated video systems are increasing in popularity, thus driving the growth of the laparoscope market.
The development of new products, including 5mm laparoscopes and deflective tip video laparoscopes, is expected to drive unit sales based on their clinical benefits. 5mm laparoscopes are narrower in frame, which is beneficial for the patient in reducing scars after surgery. Deflective tip video scopes offer convenience during surgery by providing a broader visual range for surgeons.
Karl Storz is the leading competitor in the European market for laparoscopes. The company offers their original 0° HOPKINS® rod lens scope as well as their newer ENDOCAMELEON® laparoscope. Karl Storz also offers a broad product line of standard and premium laparoscopes, such as those used for bariatric and pediatric surgery.
Olympus is the second leading competitor in the European market for laparoscopes. While Karl Storz provides the majority of the rod lens laparoscopes, Olympus is the main provider of video laparoscopes across Europe. Olympus offers their ENDOEYE® HD II video laparoscope which is an HD laparoscope line. Although there are higher quality video systems on the market, Olympus has one of the best direct sales forces in the industry, allowing them to maintain a tight hold on the video laparoscope market in Europe. Additional competitors in the European laparoscope market include Richard Wolf, Stryker, B. Braun Aesculap, ConMed, Ackermann Instrumente, Endomed, ILO Electronic, Locamed, Maxer, Schoelly, Seeman Technologies, Sopro Comey and Wisap among others.
For Further Information
More on the infusion therapy market in Europe can be found in a series of reports published by iData entitled the Europe Market Report Suite for Laparoscopy Devices. The full report suite on the Europe market for infusion therapy devices includes infusion pumps, intravenous (IV) sets, needleless connectors (NLCs) and stopcocks. These four categories are further segmented based on specific distinguishing categories. The infusion pump market is segmented into categories based on the type of pump, such large volume, syringe, electronic ambulatory and disposable infusion pumps. The intravenous set market is segmented by tubing type, such as primary IV, secondary IV and IV extension sets.
The iData series on the market for infusion therapy devices covers the U.S., Australia, Japan, South Korea and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about infusion therapy device market data or procedure data, register online or email us at email@example.com for a Europe Market Report Suite for Laparoscopy Devices brochure and synopsis.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Vascular Access, Spinal Implants and VCF, Spinal MIS, Orthopedic Trauma, Large & Small Joints, Orthopedic Soft Tissue, Orthopedic Biomaterials, Orthopedic Soft Tissue Reinforcement and Regeneration, Wound Management, Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Ophthalmics, Laparoscopy, Urology, Gynecology, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Anesthesiology and more.
We have built a reputation and earned our clients' trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Marvin Cidamon